A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

Part of paid clinical trials in Mesa, Arizona.

Sponsor
Bristol-Myers Squibb
Study ID
NCT07175285
Status
Recruiting
Apply to this trial

Conditions

  • Systemic Lupus Erythematosus (SLE)

Eligibility Criteria

Sex
ALL
Age
16 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Current standard of care treatment options — DRUG
    According to the product label

Study Details

The purpose of this study is to characterize the efficacy and safety of current standard of care treatment options in participants with active systemic lupus erythematosus (SLE; including lupus nephritis) with inadequate response to glucocorticoids and at least two immunosuppressants

Key Dates

Start date
Oct 8, 2025
Status verified
Jun 2026
Primary completion
Mar 24, 2028
Completion
Oct 5, 2032

Study Design

Enrollment
223 participants (estimated)

Arms

  • Arm: Group 1
    Participants with systemic lupus erythematosus (SLE), including Lupus Nephritis, with inadequate response to glucocorticoids and at least 2 immunosuppressants, receiving current standard of care treatment options.

Primary Outcome Measure

Number of of participants achieving Definition of Remission in Systemic Lupus Erythematosus (DORIS) at 6 months along with the 95% CI. [ Time Frame: 6 months ]

Central Contacts

  • BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
    855-907-3286
    [email protected]
  • First line of the email MUST contain NCT # and Site #.

Locations (25)

FacilityCityStateZIPSite coordinators
Local Institution - 0062MesaArizona85210
Site 0062
Local Institution - 0054La JollaCalifornia92093
Site 0054
Local Institution - 0001La PalmaCalifornia90623-1730
Site 0001
Local Institution - 0071Los AngelesCalifornia90095
Site 0071
Rheumatology Center of San DiegoSan DiegoCalifornia92128-2551
Tania Rivera, Site 0035
858-336-2810
Local Institution - 0063Fort LauderdaleFlorida33309-1715
Site 0063
South Florida RheumatologyHollywoodFlorida33021-6052
Gizem Gokalp, Site 0061
954-961-3252
LIFE Clinical TrialsMargateFlorida33063
Jigar Shah, Site 0006
786-674-8868
One- RheumatologyPalm Beach GardensFlorida33410
Clifford Stermer, Site 0068
561-559-1110
Local Institution - 0069AtlantaGeorgia30322-1013
Site 0069
Local Institution - 0065WillowbrookIllinois60527
Site 0065
Local Institution - 0064RockvilleMaryland20850
Site 0064
Local Institution - 0034Ann ArborMichigan48109-5000
Site 0034
AA MRCGrand BlancMichigan48439-2451
Ali Karrar, Site 0030
810-667-0067
Local Institution - 0070KalispellMontana59901-3129
Site 0070
Sahni Rheumatology & TherapyWest Long BranchNew Jersey07764
KIREN SAHNI, Site 0060
732-272-1456
Kings County Hospital Center - BrooklynBrooklynNew York11203
Alexander Feoktistov, Site 0039
520-834-8259
DJL Clinical Research, PLLCCharlotteNorth Carolina28211
Charles Withers, Site 0026
704-247-9179
Local Institution - 0037DurhamNorth Carolina27710-1000
Site 0037
Oklahoma Medical Research FoundationOklahoma CityOklahoma73104-5005
Cristina Arriens, Site 0019
405-271-7805
Local Institution - 0052PhiladelphiaPennsylvania19140
Site 0052
Local Institution - 0067MurfreesboroTennessee37128
Site 0067
Arthritis Care of Texas - Corpus ChristiCorpus ChristiTexas78415
Eric Chiang, Site 0066
361-400-7700
El Paso Medical Research Institute (MedResearch, Inc)El PasoTexas79902-4821
German Hernandez, Site 0027
915-544-4572
Local Institution - 0051Van VleckTexas77482
Site 0051

Find similar trials in Mesa, AZ

By research site
Local Institution - 0062· Mesa, AZLocal Institution - 0054· La Jolla, CALocal Institution - 0001· La Palma, CALocal Institution - 0071· Los Angeles, CARheumatology Center of San Diego· San Diego, CALocal Institution - 0063· Fort Lauderdale, FL

Related Studies